MarketCap
Facebook
X
Telegram
The Clorox Company Financial Ratios 2025-2011 | CLX
Brief overview of The Clorox Company's valuation and returns
Ratios are assessed across five available annual reports in the 2021–2025 interval.
Market valuation is represented by P/E 19.04x (median 37.62x), EV/EBITDA 124.49x (median 21.06x), P/S 2.17x (median 2.53x). Ratios sit near their own comparison base, with an average deviation of -9.5% from five-year medians.
The 1/P/E calculation produces a 5.3% earnings yield. It does not capture future growth or capital structure.
Returns on assets and capital are represented by ROE 2.5%, ROA 14.6%, ROCE 30.1%. Return ratios are at workable levels. The business generates positive returns, though efficiency is not exceptional.
The PEG ratio is 4.08x; investors pay a high price per unit of expected growth.
The cash conversion cycle remains near its former level at 9.5 days after 17.9 days.
Valuation takeaway
The Clorox Company's market valuation is near its own historical norm, while quality ratios provide no extreme signal.
Annual Financial Ratios The Clorox Company
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
19.0 | 64.0 | 133.1 | 37.6 | 29.5 | 26.9 | 25.7 | 21.1 | 24.4 | 26.2 | 25.2 | 20.4 | 19.7 | 17.9 | 17.6 |
P/S |
2.2 | 2.5 | 2.7 | 2.4 | 2.9 | 3.8 | 3.4 | 2.8 | 2.9 | 2.9 | 2.6 | 2.0 | 2.0 | 1.8 | 1.9 |
EPS |
6.6 | 2.3 | 1.2 | 3.8 | 5.7 | 7.5 | 6.4 | 6.4 | 5.4 | 5.0 | 4.5 | 4.3 | 4.4 | 4.1 | 4.1 |
EV (Enterprise Value) |
20.3 B | 23 B | 25 B | 22.6 B | 26.4 B | 29.7 B | 25.5 B | 21.6 B | 20.7 B | 20.8 B | 18.3 B | 15.2 B | 15.1 B | 13.9 B | 13.8 B |
EBITDA per Share |
1.77 | 1.89 | 1.91 | 1.82 | 1.68 | 1.43 | 8.8 | 8.79 | 8.74 | 8.22 | 7.74 | 7.46 | 7.46 | 8.15 | 8 |
EV/EBITDA |
124.5 | 24.5 | 21.1 | 17.4 | 16.4 | 17.3 | 16.2 | 13.7 | 13.4 | 11.0 | 10.7 | ||||
PEG |
4.08 | -5.92 | -12.6 | -3.29 | -2.49 | -1.91 | 32.78 | 1.22 | 2.91 | 2.08 | 7.75 | -14.89 | 3.55 | 9.08 | -3.42 |
P/B |
32.0 | 36.4 | 51.1 | 23.8 | 35.4 | 27.9 | 37.7 | 24.0 | 31.6 | 57.1 | 123.7 | 74.1 | 77.2 | -71.7 | -113.8 |
P/CF |
15.7 | 25.8 | 17.1 | 22.1 | 16.4 | 16.4 | 26.8 | 22.3 | 26.9 | 28.0 | 19.5 | 18.1 | 19.4 | 23.1 | 20.8 |
ROE % |
252.34 | 85.37 | 38.40 | 63.37 | 119.93 | 103.41 | 146.69 | 113.36 | 129.34 | 218.18 | 491.53 | 362.34 | 391.78 | -400.74 | -647.67 |
ROA % |
14.57 | 4.87 | 2.51 | 7.50 | 11.21 | 15.11 | 16.03 | 16.26 | 15.33 | 14.34 | 13.93 | 13.10 | 13.27 | 12.42 | 13.38 |
ROCE % |
- | - | - | - | - | - | 30.11 | 29.15 | 40.41 | 35.68 | 36.28 | 36.60 | 30.50 | 39.36 | 32.92 |
Current Ratio |
1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.2 | 0.9 | 1.1 | 0.8 | 1.0 | 1.0 | 0.9 | 1.3 | 0.7 | 0.9 |
DSO |
38.9 | 35.6 | 33.8 | 33.0 | 31.1 | 34.7 | 37.1 | 35.8 | 34.5 | 36.1 | 33.5 | 35.6 | 37.6 | 38.4 | 36.6 |
DIO |
54.4 | 60.1 | 59.1 | 60.3 | 53.1 | 48.2 | 53.6 | 53.5 | 50.7 | 51.1 | 44.1 | 43.6 | 44.8 | 44.3 | 47.1 |
DPO |
83.9 | 88.9 | 80.7 | 75.6 | 66.3 | 54.0 | 53.1 | 53.7 | 55.4 | 56.5 | 49.3 | 49.7 | 46.9 | 47.5 | 52.2 |
Operating Cycle |
93.3 | 95.7 | 92.9 | 93.3 | 84.3 | 82.9 | 90.7 | 89.3 | 85.3 | 87.2 | 77.6 | 79.3 | 82.4 | 82.7 | 83.8 |
Cash Conversion Cycle |
9.5 | 6.8 | 12.2 | 17.7 | 17.9 | 28.9 | 37.6 | 35.7 | 29.9 | 30.6 | 28.2 | 29.5 | 35.5 | 35.2 | 31.6 |
All numbers in USD currency
Quarterly Financial Ratios The Clorox Company
| 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
1.54 | 1.29 | 0.65 | - | 1.51 | 1.55 | 0.8 | - | -0.41 | 0.75 | 0.17 | - | -1.71 | 0.81 | 0.69 | 1.49 | 1.22 | 0.56 | 1.15 | 1.71 | -0.49 | 2.06 | 3.28 | 2.06 | 3.28 | 1.48 | 1.61 | 1.48 | 1.61 | 1.42 | 1.65 | 1.42 | 1.65 | 1.81 | 1.49 | 1.81 | 1.49 | 1.16 | 1.39 | 1.16 | 1.39 | 1.15 | 1.33 | 1.15 | 1.33 | 0.96 | 0.7 | 0.96 | 0.7 | 0.89 | 1.04 | 0.89 | 1.04 | 0.94 | 1.02 | 0.94 | 1.02 | 0.79 | 0.99 | 0.79 | 0.99 |
EBITDA per Share |
0.48 | 0.45 | 0.46 | - | 0.45 | 0.43 | 0.44 | - | - | - | 0.49 | - | 0.06 | - | 0.45 | 0.93 | 0.06 | - | 0.45 | 0.89 | 0.06 | - | 0.4 | 0.82 | 0.4 | - | 0.35 | 0.7 | 0.35 | - | 0.34 | 0.69 | 0.34 | - | 0.31 | 0.63 | 0.31 | - | 0.32 | 0.64 | - | - | 0.32 | 0.63 | 0.32 | - | 0.33 | 0.65 | 0.33 | - | 0.33 | 0.69 | 0.34 | - | 0.34 | 0.69 | 338 | - | 349 | 0.68 | 0.35 |
ROE % |
-670.45 | -293.45 | -8.34 | 301.60 | 281.60 | 163.70 | 46.86 | 39.45 | -83.22 | -185.89 | -208.39 | -85.37 | -52.28 | 96.44 | 90.33 | 99.15 | 101.70 | 60.81 | 68.63 | 79.89 | 72.78 | 133.32 | 144.78 | 144.47 | 149.28 | 140.48 | 131.68 | 123.07 | 114.27 | 108.38 | 114.51 | 118.64 | 124.77 | 129.17 | 153.70 | 183.21 | 202.72 | 227.56 | 247.63 | 330.23 | 406.33 | 491.82 | 461.06 | 369.77 | 324.67 | 237.35 | 266.58 | 381.23 | 378.83 | 413.54 | 559.46 | -273.44 | -443.32 | -634.99 | -907.39 | -413.45 | -444.43 | -497.07 | -171.05 | -122.09 | -151.16 |
ROA % |
10.52 | 10.99 | 11.66 | 8.64 | 7.76 | 3.50 | 1.62 | 1.06 | -2.56 | -5.31 | -5.25 | -0.61 | 2.38 | 8.38 | 7.86 | 8.74 | 9.08 | 5.75 | 8.41 | 12.27 | 13.11 | 20.75 | 20.36 | 18.00 | 17.45 | 14.73 | 14.93 | 15.32 | 15.30 | 15.49 | 16.80 | 16.82 | 18.32 | 18.36 | 16.73 | 16.56 | 14.77 | 14.54 | 14.85 | 15.04 | 15.32 | 15.49 | 14.59 | 12.56 | 11.91 | 9.90 | 9.84 | 10.84 | 10.57 | 11.61 | 11.72 | 11.36 | 11.51 | 11.41 | 11.13 | 11.51 | 11.21 | 11.28 | 3.19 | 2.52 | 3.12 |
Current Ratio |
1.0 | 1.0 | 1.0 | 1.1 | 1.0 | 1.0 | 1.0 | 1.1 | 1.1 | 1.0 | 1.0 | 1.1 | 1.0 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.2 | 1.2 | 1.2 | 1.2 | 1.1 | 1.1 | 1.1 | 1.1 | 1.2 | 1.1 | 1.2 | 1.2 | 1.2 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.0 | 1.0 | 1.0 | 1.1 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 |
DSO |
36.7 | 37.5 | 48.7 | - | 32.8 | 32.4 | 33.4 | - | 34.0 | 28.9 | 41.8 | - | 30.4 | 32.2 | 33.9 | 17.7 | 31.0 | 33.0 | 31.8 | 15.8 | 31.2 | 32.2 | 31.7 | 32.1 | 28.4 | 34.6 | 36.0 | 39.7 | 35.1 | 34.0 | 34.1 | 18.0 | 34.2 | 34.4 | 33.3 | 17.7 | 33.3 | 32.7 | 33.6 | 36.9 | 33.0 | 32.1 | 32.5 | 35.2 | 32.6 | 31.5 | 33.8 | 37.0 | 35.3 | 35.1 | 36.9 | 39.8 | 36.5 | 34.9 | 36.8 | 39.7 | 36.3 | 34.7 | 33.7 | 39.2 | - |
DIO |
57.6 | 56.9 | 60.2 | - | 60.6 | 57.1 | 58.8 | - | 57.9 | 55.4 | 75.1 | - | 60.4 | 62.3 | 61.8 | 32.2 | 63.8 | 64.5 | 61.7 | 30.2 | 61.7 | 51.9 | 45.3 | 41.2 | 44.3 | 57.3 | 55.0 | 57.7 | 59.0 | 60.3 | 52.8 | 55.6 | 51.5 | 54.0 | 50.8 | 46.8 | 53.0 | 56.7 | 51.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 37.4 | 18.7 | - | - | 26.3 | 26.1 | - | - | 27.4 | 28.6 | - | - | 26.1 | 27.9 | - | - | 27.6 | 25.5 | - | - | 27.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
94.2 | 94.3 | 108.9 | - | 93.4 | 89.5 | 92.2 | - | 91.9 | 84.3 | 116.9 | - | 90.8 | 94.6 | 95.7 | 49.9 | 94.8 | 97.5 | 93.5 | 46.0 | 92.9 | 84.1 | 77.0 | 73.3 | 72.7 | 92.0 | 91.0 | 97.4 | 94.1 | 94.2 | 86.9 | 73.7 | 85.7 | 88.4 | 84.2 | 64.5 | 86.3 | 89.4 | 85.2 | 36.9 | 33.0 | 32.1 | 32.5 | 35.2 | 32.6 | 31.5 | 33.8 | 37.0 | 35.3 | 35.1 | 36.9 | 39.8 | 36.5 | 34.9 | 36.8 | 39.7 | 36.3 | 34.7 | 33.7 | 39.2 | - |
Cash Conversion Cycle |
94.2 | 94.3 | 108.9 | - | 93.4 | 89.5 | 92.2 | - | 91.9 | 84.3 | 116.9 | - | 90.8 | 94.6 | 95.7 | 49.9 | 94.8 | 97.5 | 56.2 | 27.3 | 92.9 | 84.1 | 50.7 | 47.2 | 72.7 | 92.0 | 63.5 | 68.9 | 94.1 | 94.2 | 60.8 | 45.8 | 85.7 | 88.4 | 56.5 | 38.9 | 86.3 | 89.4 | 57.4 | 36.9 | 33.0 | 32.1 | 32.5 | 35.2 | 32.6 | 31.5 | 33.8 | 37.0 | 35.3 | 35.1 | 36.9 | 39.8 | 36.5 | 34.9 | 36.8 | 39.7 | 36.3 | 34.7 | 33.7 | 39.2 | - |
All numbers in USD currency
Multiples are an important financial analysis tool for the company The Clorox Company, allowing investors and analysts to quickly assess the company’s value and investment attractiveness based on the ratio of market indicators to the company’s financial performance. Essentially, multiples express how the market values the company relative to its earnings, revenue, equity, or other key metrics.
Advantages of Using Financial Ratios- Simplified Data Analysis
Financial ratios transform large volumes of accounting data into compact and easily interpretable indicators, significantly simplifying the assessment of the company’s condition. - Comparability Between Companies
Multiples standardize financial metrics, enabling objective comparison of companies of different sizes, industries, and market capitalizations. - Identification of Trends and Issues
Regular analysis of ratios helps track the dynamics of financial health, identify strengths and weaknesses of the business, as well as potential risks. - Decision Support
Financial multiples serve as an important tool for investors, creditors, and company management in making investment, credit, and managerial decisions. - Accelerated Assessment of Investment Attractiveness
Ratios allow quick determination of key performance, liquidity, and financial stability indicators, facilitating prompt evaluation of companies’ attractiveness for investments.
Using multiples enables comparison between companies, even if they differ in size or industry, as they standardize financial data into ratios convenient for analysis. This is especially useful for evaluating companies where direct analysis of financial statements may be complex or require in-depth knowledge.
Britain
USA
China
Bermuda
